Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H Weisman
A Qualitative Physician Focus Group Study to Determine How Physicians Decide What Second-Line Therapy to Prescribe for Patients With Type 2 Diabetes (T2DM)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Chimeric 7E3 Prevents Carotid Artery Thrombosis in Cynomolgus Monkeys
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Related publications
Diabetes Self-Management Experience: A Focus Group Study of Taiwanese Patients With Type 2 Diabetes
Journal of Clinical Nursing
Medicine
Nursing
Barriers to Medication Taking Among Kuwaiti Patients With Type 2 Diabetes: A Qualitative Study
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Exploring Patients’ Perceptions for Insulin Therapy in Type 2 Diabetes: A Brazilian and Canadian Qualitative Study
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Insulin for Type 2 Diabetes: Choosing a Second-Line Insulin Regimen
International Journal of Clinical Practice
Medicine
“Limit Work to Here and Now”—A Focus Group Study on How Emergency Physicians View Their Work in Relation to Patients’ Drug Treatment
International Journal of Qualitative Studies on Health and Well-being
Gerontology
Health Policy
Fundamentals
Skills
Legal Aspects
Ethics
Issues
Q192R Paraoxonase Gene 1 (PON1) Polymorphism and Atorvastatin Therapy Effect in Patients With Type 2 Diabetes Mellitus (T2DM)
The Scientific Notes of the I. P. Pavlov St. Petersburg State Medical University
Switching Multiple Sclerosis Patients With Breakthrough Disease to Second-Line Therapy
PLoS ONE
Multidisciplinary
Safe and Effective Prescription of Metformin in Elderly Patients With Type 2 Diabetes (T2DM)
Endocrinology&Metabolism International Journal
The Cost-Effectiveness of Canagliflozin Versus Sitagliptin as Third-Line Therapy in Type 2 Diabetes Mellitus (T2dm) in a Canadian Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
